Skip to main content
NanoGroup S.A. logo

NanoGroup S.A. — Investor Relations & Filings

Ticker · NNG ISIN · PLNNGRP00011 LEI · 259400HXWEAZUWRLY648 WAR Professional, scientific and technical activities
Filings indexed 987 across all filing types
Latest filing 2026-04-23 Regulatory Filings
Country PL Poland
Listing WAR NNG

About NanoGroup S.A.

https://en.nanogroup.eu/

NanoGroup S.A. is a biotechnology company specializing in the application of nanotechnology to medicine. The company focuses on developing and licensing early-stage, pre-clinical, and Investigational New Drug (IND) solutions. Its research and development activities are concentrated on addressing critical medical needs, primarily in the fields of oncology and transplantology. Key areas of interest include innovative anticancer therapies utilizing RNA, regenerative medicine, early diagnostics, and the development of advanced organ perfusion systems for transplantation.

Recent filings

Filing Released Lang Actions
Ocena Rady Nadzorczej - podpisy
Regulatory Filings
2026-04-23 Polish
Ocena Rady Nadzorczej
Regulatory Filings
2026-04-23 Polish
Oświadczenie Zarządu o zgodności sprawozdania- podpisy
Regulatory Filings
2026-04-23 Polish
Oświadczenie Zarządu o zgodności sprawozdania
Regulatory Filings
2026-04-23 Polish
Informacja Zarządu - firma audytorska - podpisy
Regulatory Filings
2026-04-23 Polish
Informacja Zarządu - firma audytorska
Regulatory Filings
2026-04-23 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.